Authors: Lin, XH Tascilar, M Lee, WH Vles, WJ Lee, BH Veeraswamy, R Asgari, K Freije, D van Rees, B Gage, WR Bova, GS Isaacs, WB Brooks, JD DeWeese, TL De Marzo, AM Nelson, WG

Citation: Xh. Lin et al., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells, AM J PATH, 159(5), 2001, pp. 1815-1826

Authors: Shepard, TF Platz, EA Kantoff, PW Nelson, WG Isaacs, WB Freije, D Febbo, PG Stampfer, MJ Giovannucci, E

Citation: Tf. Shepard et al., No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study, CANC EPID B, 9(11), 2000, pp. 1267-1268

Authors: Tchou, JC Lin, XH Freije, D Isaacs, WB Brooks, JD Rashid, A De Marzo, AM Kanai, Y Hirohashi, S Nelson, WG

Citation: Jc. Tchou et al., GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas, INT J ONCOL, 16(4), 2000, pp. 663-676

Authors: Kibel, AS Freije, D Isaacs, WB Bova, GS

Citation: As. Kibel et al., Deletion mapping at 12p12-13 in metastatic prostate cancer, GENE CHROM, 25(3), 1999, pp. 270-276

Authors: Wilkens, EP Freije, D Xu, JF Nusskern, DR Suzuki, H Isaacs, SD Wiley, K Bujnovszky, P Meyers, DA Walsh, PC Isaacs, WB

Citation: Ep. Wilkens et al., No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer, PROSTATE, 39(4), 1999, pp. 280-284